Newsletter
Newsletter Support JNS

FDA clears new ReWalk product for stroke survivors

Israel-based ReWalk Robotics Ltd. announced that its ReStore product will have a starting price in the United States of $28,900, though leasing options will be available.

ReWalk Robotics Ltd.’s ReStore, an exoskeleton for stroke survivors. Credit: Screenshot.
ReWalk Robotics Ltd.’s ReStore, an exoskeleton for stroke survivors. Credit: Screenshot.

The Food and Drug Administration has cleared a new product geared to help stroke survivors walk again.

Israel-based ReWalk Robotics Ltd. announced on Tuesday that its ReStore product will have a starting price in the United States of $28,900, though leasing options will be available.

Last week, ReStore received the CE mark, allowing it to be sold in the European Union.

ReWalk Robotics Ltd. is known for its exoskeleton that enables paraplegics to walk again. It received FDA clearance in 2014.

Days earlier, a Jewish security group warned police about a heightened security risk at the Chanukah event.
The prominent Jewish Democrat says she will use her “seniority and clout” in a district that has long elected Black representatives.
The first such legal move on behalf of a Palestinian against the terror group at the International Criminal Court has gone unanswered since December.
A 25-year-old faces hate crime charges after two Jewish men were attacked near a Hendon shul.
“I do think perhaps there is the possibility that in the next few hours the world will get some good news,” Washington’s top diplomat said.
A Shavuot benefit at Jerusalem’s Tower of David raised funds for HaGal Sheli’s surfing-based rehabilitation programs.